FDA's HVD SAS Code from Progesterone Guidance [RSABE / ABEL]

posted by jag009  – NJ, 2013-04-22 18:39 (4799 d 17:28 ago) – Posting: # 10458
Views: 35,320

Hi everyone,

I am getting some strange results using the FDA Progesterone Scaled Average Bioequivalence SAS Code → The portion to compute the Unscaled Average 90% C.I.

PROC MIXED
data=pk;
CLASSES SEQ SUBJ PER TRT;
MODEL LAUCT = SEQ PER TRT/ DDFM=SATTERTH;
RANDOM TRT/TYPE=FA0(2) SUB=SUBJ G;
REPEATED/GRP=TRT SUB=SUJ;
ESTIMATE 'T vs. R' TRT 1 -1/CL ALPHA=0.1;
ods output Estimates=unsc1;
title1 'unscaled BE 90% CI - guidance version';
title2 'AUCt';
run; data unsc1;
set unsc1;
unscabe_lower=exp(lower);
unscabe_upper=exp(upper);
run;


Should the Test/Reference Ratio from the Scaled Average BE computation be similar (if not the same) as the ratio computed from the above Unscaled Average BE code?

Thanks
John


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
119 visitors (0 registered, 119 guests [including 30 identified bots]).
Forum time: 12:08 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5